Walter Jonat

Author PubWeight™ 75.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 2005 4.62
2 Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. J Clin Oncol 2009 4.12
3 Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. J Clin Oncol 2006 3.52
4 Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study. J Clin Oncol 2007 2.76
5 Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential. Oncogene 2005 1.80
6 One-step nucleic acid amplification-a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group. Virchows Arch 2008 1.75
7 A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer. Breast Cancer Res Treat 2005 1.53
8 Expression and regulation of tumor suppressor gene maspin in breast cancer. Clin Breast Cancer 2002 1.49
9 Limited relevance of the CHEK2 gene in hereditary breast cancer. Int J Cancer 2004 1.49
10 Clinical diagnosis and treatment of ectopic pregnancy. Obstet Gynecol Surv 2013 1.25
11 Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group. J Clin Oncol 2005 1.09
12 Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochem Biophys Res Commun 2002 1.04
13 Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis. Int J Cancer 2003 1.02
14 First-line trastuzumab plus epirubicin and cyclophosphamide therapy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: cardiac safety and efficacy data from the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) trial. J Clin Oncol 2010 1.01
15 Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects. J Cancer Res Clin Oncol 2008 0.99
16 Detection of granulocyte colony-stimulating factor and its receptor in human follicular luteinized granulosa cells. Fertil Steril 2004 0.98
17 In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells. BMC Cancer 2010 0.96
18 An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma. Clin Cancer Res 2007 0.96
19 CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93). Eur J Cancer 2006 0.95
20 Amplification of the BCAS2 gene at chromosome 1p13.3-21 in human primary breast cancer. Cancer Lett 2002 0.95
21 Combined surgical and hormone therapy for endometriosis is the most effective treatment: prospective, randomized, controlled trial. J Minim Invasive Gynecol 2013 0.94
22 Establishing a control population to screen for the occurrence of nineteen unclassified variants in the BRCA1 gene by denaturing high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2002 0.93
23 Certification of breast centres in Germany: proof of concept for a prototypical example of quality assurance in multidisciplinary cancer care. BMC Cancer 2009 0.93
24 Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer). Breast Care (Basel) 2009 0.92
25 Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling. Cancer Lett 2008 0.92
26 Expression and regulation of tumor suppressor gene maspin in human bladder cancer. Cancer Lett 2004 0.92
27 Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol 2011 0.91
28 Optimizing the quality of breast cancer care at certified german breast centers: a benchmarking analysis for 2003-2009 with a particular focus on the interdisciplinary specialty of radiation oncology. Strahlenther Onkol 2011 0.91
29 Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. Cancer Lett 2003 0.89
30 DNA-methylation profiling of fetal tissues reveals marked epigenetic differences between chorionic and amniotic samples. PLoS One 2012 0.88
31 Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer. Exp Mol Pathol 2012 0.87
32 Expression of metastasis suppressor gene maspin is reduced in breast cancer brain metastases and correlates with the estrogen receptor status. Neurol Res 2009 0.87
33 Results of the Zometa cost-utility model for the german healthcare system based on the results of the ABCSG-12 study. Onkologie 2010 0.86
34 Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer. PLoS One 2012 0.86
35 A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer - GABG-IV B-93. Eur J Cancer 2007 0.86
36 Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer. Breast Care (Basel) 2008 0.85
37 Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines. J Cancer Res Clin Oncol 2010 0.85
38 A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer. Breast Cancer Res Treat 2012 0.84
39 Sunitinib (SU11248) inhibits growth of human ovarian cancer in xenografted mice. Anticancer Res 2010 0.83
40 Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer. Curr Med Res Opin 2006 0.83
41 Significance of CA 125 serum level in discrimination between benign and malignant masses in the pelvis. Arch Gynecol Obstet 2003 0.83
42 Leiomyomatosis peritonealis disseminata in a pregnant woman. Arch Gynecol Obstet 2009 0.82
43 Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management. Breast Cancer Res Treat 2012 0.82
44 Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report. Arch Gynecol Obstet 2008 0.82
45 Mastitis nonpuerperalis after nipple piercing: time to act. Int J Fertil Womens Med 2003 0.82
46 Expression of mRNA and protein of macrophage colony-stimulating factor and its receptor in human follicular luteinized granulosa cells. Fertil Steril 2005 0.81
47 Early detection of a twin tubal pregnancy by Doppler sonography allows fertility-conserving laparoscopic surgery. Arch Gynecol Obstet 2008 0.81
48 Fetal transabdominal anatomy scanning using standard views at 11 to 14 weeks' gestation. Am J Obstet Gynecol 2005 0.80
49 Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer - a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system. Onkologie 2010 0.80
50 Diagnosis and management of an unilateral giant fibroadenoma of the breast in pregnancy. Arch Gynecol Obstet 2011 0.80
51 Normal mammary fibroblasts induce reversion of the malignant phenotype in human primary breast cancer. Anticancer Res 2013 0.79
52 Normal prenatal ultrasound findings in a case with de novo mosaic small supernumerary marker chromosome 18--how to counsel? J Matern Fetal Neonatal Med 2011 0.79
53 Circulating level of macrophage colony-stimulating factor can be predictive for human in vitro fertilization outcome. Fertil Steril 2008 0.78
54 Differential interleukin-6 messenger ribonucleic acid expression and its distribution pattern in eutopic and ectopic endometrium. Fertil Steril 2007 0.78
55 Nilotinib in combination with carboplatin and paclitaxel is a candidate for ovarian cancer treatment. Oncology 2014 0.78
56 Apoptosis resistance in endometriosis. Bioimpacts 2011 0.78
57 Actual management of ductal carcinoma in situ of the breast. Arch Gynecol Obstet 2009 0.78
58 Precarious preoperative diagnostics and hints for the laparoscopic excision of uterine adenomatoid tumors: two exemplary cases and literature review. Fertil Steril 2010 0.77
59 The incidence of complications by hysterectomy for benign disease in correlation to an assumed preoperative score. Arch Gynecol Obstet 2014 0.77
60 Characterization of two supernumerary marker chromosomes in a patient with signs of Klinefelter syndrome, mild facial anomalies, and severe speech delay. Am J Med Genet A 2006 0.77
61 Application of ex vivo micro-computed tomography for assessment of in vivo fluorescence and plain radiographic imaging for monitoring bone metastases and osteolytic lesions. J Bone Miner Metab 2011 0.77
62 Earliest ultrasound findings and description of splicing mutations in Meckel-Gruber syndrome. Arch Gynecol Obstet 2012 0.77
63 Circulating concentration of stem cell factor in serum of stimulated IVF patients. Reprod Biomed Online 2010 0.77
64 Organ-preserving management of ovarian pregnancies by laparoscopic approach. Fertil Steril 2011 0.77
65 Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancer. Oncology 2014 0.77
66 Premature ovarian failure in a patient with a complex chromosome rearrangement involving the critical region Xq24, characterized by analysis using fluorescence in situ hybridization by chromosome microdissection. Fertil Steril 2007 0.76
67 Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signals. Cancer Lett 2012 0.76
68 Gentle strength training in rehabilitation of breast cancer patients compared to conventional therapy. Anticancer Res 2012 0.76
69 Chronic isolated torsion of the left fallopian tube: a diagnostic dilemma. Arch Gynecol Obstet 2007 0.76
70 Biomechanics of the female pelvic floor: a prospective trail of the alteration of force-displacement-vectors in parous and nulliparous women. Arch Gynecol Obstet 2011 0.76
71 The t(14,15) in mouse strain CBA/CaH-T(14;15)6Ca/J causes a break in the ADAMTS12 gene. Comp Med 2010 0.75
72 Fetal hypoplastic left heart syndrome and maternal liver transplantation for Wilson's disease: a case report. J Med Case Rep 2013 0.75
73 Oocyte morphology on day 0 correlates with aneuploidy as detected by polar body biopsy and FISH. Arch Gynecol Obstet 2013 0.75
74 Expanding role of ovarian suppression/ablation in premenopausal ER-positive breast cancer: issues and opportunities. Oncology (Williston Park) 2009 0.75
75 Preclinical evaluation of sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases. BMC Cancer 2013 0.75
76 Chromosomal mosaicisms in prenatal diagnosis: correlation with first trimester screening and clinical outcome. J Perinat Med 2012 0.75
77 Sham-controlled implantation after preimplantation genetic screening by polar body biopsy and FISH. Arch Gynecol Obstet 2013 0.75
78 [For postmenopausal women with hormone-dependent tumors. Aromatase inhibitors are the new gold standard]. MMW Fortschr Med 2006 0.75
79 Double inferior vena cava: a crucial finding complicating para-aortic lymphadenectomy. Eur J Obstet Gynecol Reprod Biol 2010 0.75
80 Evaluation of two different vacuum-assisted breast biopsy systems: Mammotome(R) system 11G/8G vs. ATEC(R) system 12G/9G. Acta Radiol 2013 0.75
81 3-D ultrasound imaging of a prenatally diagnosed Beckwith-Wiedemann syndrome. Arch Gynecol Obstet 2011 0.75
82 Clinical implications of first and multiple locoregional breast cancer recurrences. Arch Gynecol Obstet 2014 0.75
83 [Pregnant patient wants to delivery anonymously. Obstetrician in legal conflict (interview by Maria Weiss)]. MMW Fortschr Med 2008 0.75
84 Distended jugular lymphatic sacs in fetuses with increased nuchal translucency: correlation with first-trimester findings in aberrant karyotypes. J Matern Fetal Neonatal Med 2013 0.75
85 Simultaneous congener-specific determination of selected organochlorine compounds and nitro musks in human whole blood samples by solid-phase extraction and capillary gas chromatography with electron capture detection. J Anal Toxicol 2005 0.75
86 Influence of arm crank ergometry on development of lymphedema in breast cancer patients after axillary dissection: A randomized controlled trail. J Rehabil Med 2017 0.75
87 Microdochectomy in the management of pathologic nipple discharge. Arch Gynecol Obstet 2010 0.75
88 Assessment of reliability endometrial brush cytology in detection etiology of late postmenopausal bleedings. Arch Gynecol Obstet 2002 0.75
89 Congenital retroperitoneal vascular anomalies: impact on pelvic surgery. Arch Gynecol Obstet 2010 0.75
90 Pathologic ultrasound findings and risk for congenital anomalies in teenage pregnancies. J Matern Fetal Neonatal Med 2012 0.75
91 [Masses in the pelvis minor]. Ther Umsch 2007 0.75
92 Perinatal management of pregnancies with severe fetal heart defects and epigenetic aspects. J Matern Fetal Neonatal Med 2012 0.75